By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

XTL Biopharmaceuticals Ltd. 

Kiryat Weizmann, Science Park, Bldg 3
P.O. Box 370
Rehovot    76100  Israel
Phone: 972-8-932-4444 Fax: 972-8-930-4445


SEARCH JOBS








Company News
XTL Biopharma (XTLB) To Present At ChinaBio Partnering Forum 2016 In Suzhou, China On May 19, 2016 5/16/2016 11:31:47 AM
XTL Biopharma (XTLB) Reports 2015 Financial Results & Provides Clinical And Operational Update 3/31/2016 10:24:13 AM
XTL Biopharma (XTLB) Completes Phase 2 Trial Design For Lead Compound hCDR1 In The Treatment Of Lupus 3/21/2016 6:44:41 AM
Lupus Thought Leader Daphna Paran, MD, Named Medical Director Of XTL Biopharma (XTLB) 3/9/2016 6:58:36 AM
XTL Biopharma (XTLB) Expands Global IP Portfolio With Issued Patent In Hungary For Lupus Drug Hcdr1 3/2/2016 7:50:18 AM
XTL Biopharma (XTLB) Receives European Medicines Agency's SME Status 2/22/2016 11:00:30 AM
XTL Biopharma (XTLB)' Lupus Drug hCDR1 Granted Patent For Pharmaceutical Composition & Manufacturing Processes 2/10/2016 6:51:47 AM
XTL Biopharma (XTLB) Joins Corporate Advisory Council Of The Lupus Foundation Of America 1/27/2016 10:01:19 AM
XTL Biopharmaceuticals Ltd. (XTLB) Announces Encouraging Feedback From U.S. FDA On Its Upcoming IND Filing For Lupus Drug Hcdr1 1/25/2016 7:25:41 AM
XTL Biopharmaceuticals Ltd. (XTLB) Advances Formulation Of Its hCDR1 Drug For Clinical Trials In The Treatment Of Lupus Through Use Of Cydex Pharmaceuticals' Captisol 1/13/2016 8:03:48 AM
12345678910
//-->